Ranbaxy Laboratories Ltd

Ranbaxy falls on media report of US FDA query on plant

Business Standard said the FDA had issued form 483 to Ranbaxy regarding its Mohali plant. That form is issued when U.S. inspectors see conditions they believe may violate US rules.

SC to hear next week PIL against Ranbaxy Laboratories

The Supreme Court on Friday agreed to hear next week a PIL seeking cancellation of licence granted to Ranbaxy Laboratories Ltd and for initiating probe against it for allegedly manufacturing and selling adulterated medicines.

Ranbaxy starts generic Lipitor shipments from India

Suzuki Motorcycle India Pvt. Ltd., a subsidiary of one of the world’s leading two-wheeler manufacturer Suzuki Motor Corporation, registered a 28.5% increase in their March 2012 sales figures as compared to March 2011.